Aspira Women's Health Inc. of AUSTIN, TX filed a DEF 14A with the SEC on 2023-03-30. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | EX-101.SCH | XBRL TAXONOMY EXTENSION SCHEMA |
| 3 | EX-101.DEF | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE |
| 4 | EX-101.LAB | XBRL TAXONOMY EXTENSION LABEL LINKBASE |
| 5 | EX-101.PRE | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 10 | XML | EXTRACTED XBRL INSTANCE DOCUMENT |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-05-29 | DEFA14A |
| 2026-04-28 | DEFA14A |
| 2026-04-24 | DEF 14A |
| 2025-04-22 | DEFR14A |
| 2025-04-11 | DEF 14A |
| 2025-03-31 | PRE 14A |
| 2024-05-10 | DEFA14A |
| 2024-04-01 | DEFA14A |
| 2024-04-01 | DEF 14A |
| 2023-04-04 | DEFA14A |
| 2023-03-30 | DEF 14A |
| 2023-03-20 | PRE 14A |